Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.

Chandler KB, Alamoud KA, Stahl VL, Nguyen BC, Kartha VK, Bais MV, Nomoto K, Owa T, Monti S, Kukuruzinska MA, Costello CE.

Mol Omics. 2020 Mar 23. doi: 10.1039/d0mo00009d. [Epub ahead of print]

PMID:
32203567
2.

Lysyl Oxidase-Like 2 Protects against Progressive and Aging Related Knee Joint Osteoarthritis in Mice.

Tashkandi M, Ali F, Alsaqer S, Alhousami T, Cano A, Martin A, Salvador F, Portillo F, C Gerstenfeld L, Goldring MB, Bais MV.

Int J Mol Sci. 2019 Sep 27;20(19). pii: E4798. doi: 10.3390/ijms20194798.

3.

Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.

Bais MV.

J Dent Res. 2019 Mar;98(3):268-276. doi: 10.1177/0022034518816947. Epub 2019 Jan 7.

4.

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.

Kartha VK, Alamoud KA, Sadykov K, Nguyen BC, Laroche F, Feng H, Lee J, Pai SI, Varelas X, Egloff AM, Snyder-Cappione JE, Belkina AC, Bais MV, Monti S, Kukuruzinska MA.

Genome Med. 2018 Jul 20;10(1):54. doi: 10.1186/s13073-018-0569-7.

5.

Measurement of lysyl oxidase activity from small tissue samples and cell cultures.

Trackman PC, Bais MV.

Methods Cell Biol. 2018;143:147-156. doi: 10.1016/bs.mcb.2017.08.009. Epub 2017 Oct 28.

PMID:
29310775
6.

Targeting oral cancer epigenome via LSD1.

Bais MV.

Aging (Albany NY). 2017 Dec 11;9(12):2455-2456. doi: 10.18632/aging.101343. No abstract available.

7.

Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis.

Alsaqer SF, Tashkandi MM, Kartha VK, Yang YT, Alkheriji Y, Salama A, Varelas X, Kukuruzinska M, Monti S, Bais MV.

Oncotarget. 2017 Jul 27;8(43):73372-73386. doi: 10.18632/oncotarget.19637. eCollection 2017 Sep 26.

8.

LOXL2 as a protective in osteoarthritis cartilage.

Bais MV, Goldring MB.

Aging (Albany NY). 2017 Oct 27;9(10):2024-2025. doi: 10.18632/aging.101317. No abstract available.

9.

Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.

Alshenibr W, Tashkandi MM, Alsaqer SF, Alkheriji Y, Wise A, Fulzele S, Mehra P, Goldring MB, Gerstenfeld LC, Bais MV.

Arthritis Res Ther. 2017 Aug 2;19(1):179. doi: 10.1186/s13075-017-1388-8.

10.

Corrigendum to "Orthotopic non-metastatic and metastatic oral cancer mouse models" [Oral Oncol. 51(5) (2015) 476-482].

Bais MV, Kukuruzinska M, Trackman PC.

Oral Oncol. 2017 Sep;72:201. doi: 10.1016/j.oraloncology.2017.07.007. Epub 2017 Jul 22. No abstract available.

PMID:
28743466
11.

TGF-β1- and CCN2-Stimulated Sirius Red Assay for Collagen Accumulation in Cultured Cells.

Trackman PC, Saxena D, Bais MV.

Methods Mol Biol. 2017;1489:481-485.

PMID:
27734398
12.

Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.

Stanford EA, Ramirez-Cardenas A, Wang Z, Novikov O, Alamoud K, Koutrakis P, Mizgerd JP, Genco CA, Kukuruzinska M, Monti S, Bais MV, Sherr DH.

Mol Cancer Res. 2016 Aug;14(8):696-706. doi: 10.1158/1541-7786.MCR-16-0069. Epub 2016 Apr 29.

13.

Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.

Alsulaiman M, Bais MV, Trackman PC.

J Cell Commun Signal. 2016 Mar;10(1):17-31. doi: 10.1007/s12079-015-0311-9. Epub 2015 Dec 1.

14.

Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.

Ozdener GB, Bais MV, Trackman PC.

Mol Oncol. 2016 Jan;10(1):1-23. doi: 10.1016/j.molonc.2015.07.005. Epub 2015 Aug 6.

15.

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

Hiemer SE, Zhang L, Kartha VK, Packer TS, Almershed M, Noonan V, Kukuruzinska M, Bais MV, Monti S, Varelas X.

Mol Cancer Res. 2015 Jun;13(6):957-68. doi: 10.1158/1541-7786.MCR-14-0580. Epub 2015 Mar 20.

16.

Orthotopic non-metastatic and metastatic oral cancer mouse models.

Bais MV, Kukuruzinska M, Trackman PC.

Oral Oncol. 2015 May;51(5):476-82. doi: 10.1016/j.oraloncology.2015.01.012. Epub 2015 Feb 11.

17.

A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia.

Khosravi R, Sodek KL, Xu WP, Bais MV, Saxena D, Faibish M, Trackman PC.

PLoS One. 2014 Jun 27;9(6):e100669. doi: 10.1371/journal.pone.0100669. eCollection 2014.

18.

Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.

Bais MV, Ozdener GB, Sonenshein GE, Trackman PC.

Oncogene. 2015 Apr 9;34(15):1928-37. doi: 10.1038/onc.2014.147. Epub 2014 Jun 2.

19.

Skeletal trauma generates systemic BMP2 activation that is temporally related to the mobilization of CD73+ cells.

Marsell R, Steen B, Bais MV, Mortlock DP, Einhorn TA, Gerstenfeld LC.

J Orthop Res. 2014 Jan;32(1):17-23. doi: 10.1002/jor.22487. Epub 2013 Sep 9.

20.

Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide.

Eliades A, Papadantonakis N, Matsuura S, Mi R, Bais MV, Trackman P, Ravid K.

Cell Cycle. 2013 Apr 15;12(8):1242-50. doi: 10.4161/cc.24312. Epub 2013 Mar 21.

21.

Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts.

Bais MV, Nugent MA, Stephens DN, Sume SS, Kirsch KH, Sonenshein GE, Trackman PC.

PLoS One. 2012;7(2):e31188. doi: 10.1371/journal.pone.0031188. Epub 2012 Feb 8.

22.

Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration.

Bais MV, Shabin ZM, Young M, Einhorn TA, Kotton DN, Gerstnefeld LC.

Biochem Biophys Res Commun. 2012 Jan 6;417(1):211-6. doi: 10.1016/j.bbrc.2011.11.087. Epub 2011 Nov 28.

23.

Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.

Iftikhar M, Hurtado P, Bais MV, Wigner N, Stephens DN, Gerstenfeld LC, Trackman PC.

J Biol Chem. 2011 Jan 14;286(2):909-18. doi: 10.1074/jbc.M110.155622. Epub 2010 Nov 11.

24.

Time course of Newcastle disease virus-induced apoptotic pathways.

Ravindra PV, Tiwari AK, Ratta B, Bais MV, Chaturvedi U, Palia SK, Sharma B, Chauhan RS.

Virus Res. 2009 Sep;144(1-2):350-4. doi: 10.1016/j.virusres.2009.05.012. Epub 2009 Jun 6.

PMID:
19501124
25.

BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells.

Bais MV, Wigner N, Young M, Toholka R, Graves DT, Morgan EF, Gerstenfeld LC, Einhorn TA.

Bone. 2009 Aug;45(2):254-66. doi: 10.1016/j.bone.2009.04.239. Epub 2009 May 3.

26.

Novel Rath peptide for intracellular delivery of protein and nucleic acids.

Bais MV, Kumar S, Tiwari AK, Kataria RS, Nagaleekar VK, Shrivastava S, Chindera K.

Biochem Biophys Res Commun. 2008 May 23;370(1):27-32. doi: 10.1016/j.bbrc.2008.03.023. Epub 2008 Mar 17.

PMID:
18346454
27.

Bluetongue virus induces apoptosis in cultured mammalian cells by both caspase-dependent extrinsic and intrinsic apoptotic pathways.

Nagaleekar VK, Tiwari AK, Kataria RS, Bais MV, Ravindra PV, Kumar S.

Arch Virol. 2007;152(9):1751-6. Epub 2007 May 26.

PMID:
17530353
28.

Sequence analysis of an Indian field isolate of infectious bursal disease virus shows six unique amino acid changes in the VP1 gene.

Bais MV, Kataria RS, Tiwari AK, Viswas KN, Reddy AV, Prasad N.

Vet Res Commun. 2004 Oct;28(7):641-6. No abstract available.

PMID:
15563111
29.

Isolates of infectious bursal disease virus from India are of very virulent phenotype.

Indervesh, Tiwari AK, Kataria RS, Viswas KN, Bais MV, Suryanarayana VV.

Acta Virol. 2003;47(3):173-7.

PMID:
14658846
30.

Sequence analysis of segment a of a field virus isolate from an outbreak of Infectious bursal disease in India.

Bais MV, Kataria RS, Tiwari AK, Indervesh, Suryanarayana VV, Das SK.

Acta Virol. 2003;47(2):73-7.

PMID:
14524472

Supplemental Content

Support Center